moreView todays social media effects on ASTMView the latest stocks trending across Twitter. Click to view dashboardSee who Aastrom is hiring next, click here to view […]
[GlobeNewswire] – ANN ARBOR, Mich. — Aastrom Biosciences, Inc. , the leading developer of patient-specific expanded multicellular therapies for the treatment of severe chronic cardiovascular diseases, announces the following … moreView todays social media effects on ASTMView the latest stocks trending across Twitter. Click to view dashboardSee who Aastrom is hiring next, click here to view […]
moreView todays social media effects on ASTMView the latest stocks trending across Twitter. Click to view dashboardSee who Aastrom is hiring next, click here to view […]
[at Seeking Alpha] – Nick Colangelo Thank you, Mike and good afternoon everyone. During the fourth quarter, we completed several important initiatives to enhance shareholder value and strengthen the company’s position moving … moreView todays social media effects on ASTMView the latest stocks trending across Twitter. Click to view dashboardSee who Aastrom is hiring next, click here to view […]
[at noodls] – ANN ARBOR, Mich., April 19, 2013 (GLOBE NEWSWIRE) — Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded multicellular therapies for the treatment of severe, chronic … moreView todays social media effects on ASTMView the latest stocks trending across Twitter. Click to view dashboardSee who Aastrom is hiring next, click here to view […]
[at noodls] – ANN ARBOR, Mich., April 4, 2013 (GLOBE NEWSWIRE) — Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded multicellular therapies for the treatment of severe chronic … moreView todays social media effects on ASTMView the latest stocks trending across Twitter. Click to view dashboardSee who Aastrom is hiring next, click here to view […]
[at noodls] – Focus shifted to Phase 2b ixCELL-DCM clinical study and the development of ixmyelocel-T for dilated cardiomyopathy, an orphan drug indication. Company to stop enrollment and end Phase 3 REVIVE CLI study … moreView todays social media effects on ASTMView the latest stocks trending across Twitter. Click to view dashboardSee who Aastrom is hiring next, click here to […]
[at noodls] – Conference Call Today at 4:30 PM Eastern Time ANN ARBOR, Mich., March 18, 2013 (GLOBE NEWSWIRE) — Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded multicellular … moreView todays social media effects on ASTMView the latest stocks trending across Twitter. Click to view dashboardSee who Aastrom is hiring next, click here to view […]
[at noodls] – ANN ARBOR, Mich., March 6, 2013 (GLOBE NEWSWIRE) — Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic … moreView todays social media effects on ASTMView the latest stocks trending across Twitter. Click to view dashboardSee who Aastrom is hiring next, click here to view […]
[at noodls] – ANN ARBOR, Mich., Oct. 29, 2012 (GLOBE NEWSWIRE) — Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic … moreView todays social media effects on ASTMView the latest stocks trending across Twitter. Click to view dashboard […]
